Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (4)
  • GSK-3
    (3)
  • HIV Protease
    (6)
  • MAPK
    (3)
  • PGE Synthase
    (3)
  • PI3K
    (7)
  • PKC
    (4)
  • Phosphatase
    (4)
  • Pim
    (4)
  • Others
    (194)
Filter
Search Result
Results for "

HPGDS inhibitor1

" in TargetMol Product Catalog
  • Inhibitor Products
    301
    TargetMol | Activity
  • Peptides Products
    7
    TargetMol | inventory
  • PROTAC Products
    2
    TargetMol | natural
CD38 inhibitor 1
T149131700637-55-3
CD38 inhibitor 1 is an inhibitor of CD38. For hCD38 and mouse CD38, the IC50s are 7.3 nM and 1.9 nM.
  • $51
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Cyt-PTPε Inhibitor-1
T10927428478-94-8In house
Cyt-PTPε Inhibitor-1 (A Inhibitor-1) is an inhibitor of cytosolic protein tyrosine phosphatase ε. Cyt-PTPε Inhibitor-1 blocks the dephosphorylation of c-Src and exhibits anti-osteoclastic activity.
  • $58
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Edg-2 receptor inhibitor 1
T45211195941-38-8
Edg-2 receptor inhibitor 1 (SAR-100842) is an Edg-2 receptor inhibitor extracted (IC50: <0.1 μM).
  • $98
In Stock
Size
QTY
Perilipin-1/5 Inhibitor 1
T50101847939-23-5
1-[4-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)piperazin-1-yl]-2-(6-methyl-1-benzofuran-3-yl)ethan-1-one Yes An organic structural unit.
  • $171
In Stock
Size
QTY
RAS GTPase inhibitor 1
T126922252242-32-1In house
RAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.
  • $373 TargetMol
In Stock
Size
QTY
TargetMol | Citations Cited
Collagen proline hydroxylase inhibitor-1
T10861223663-32-9In house
Collagen proline hydroxylase inhibitor-1 exhibits antifibroproliferative activity.
  • $197
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Cot inhibitor-1 hydrochloride
T10865L In house
Cot inhibitor-1 hydrochloride is an inhibitor of tumor progression loci-2 kinase (IC50 = 28 nM) and inhibits the production of TNF-α in human whole blood (IC50 = 5.7 nM).
  • $127
In Stock
Size
QTY
TargetMol | Inhibitor Sale
G6Pase catalytic subunit 1 inhibitor 1
T50029237402-29-8
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine (2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine) is a heterocyclic compound. It inhibits monoamine oxidase, resulting in elevated monoamine levels in the body. It can also inhibit adenosine deaminase, resulting in elevated levels of adenosine in the body. It can also increase the activity of certain neurotransmitters, including serotonin and dopamine.
  • $68
In Stock
Size
QTY
K-transporting ATPase α chain 1 Inhibitor 1
T9553816450-73-4In house
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-car is a H+/K+ ATPase inhibitor with IC50 of 0.38μM.
  • $148
In Stock
Size
QTY
TargetMol | Inhibitor Sale
JAK1/2/3 Inhibitor 1
T7750416234-14-3
JAK1/2/3 Inhibitor 1 is a potent protein kinase inhibitor.JAK1/2/3 Inhibitor 1 has antitumor activity that inhibits the growth of a variety of cancer cell lines. It inhibits the growth of cancer cells by binding to the cancer cell backbone and inhibiting the production of new proteins.
  • $50
In Stock
Size
QTY
TargetMol | Inhibitor Sale
LSKL, Inhibitor of Thrombospondin TSP-1 2TFA
T7676
LSKL, Inhibitor of Thrombospondin TSP-1 2TFA is activation of TGF-β .
  • $45
In Stock
Size
QTY
CDK4/6/1 Inhibitor
T107352099128-41-1In house
CDK4/6/1 Inhibitor (Crozbaciclib) is a type of CDK4/6 inhibitor (IC50s: 3 and 1 nM). CDK4/6 inhibitor is a class of compounds used for the treatment of some types of hormone receptor positive, HER2-negative breast cancer, which can block the process of breast cancer cell division and reproduction.
  • $329
In Stock
Size
QTY
IDO inhibitor 1
T76601204669-37-3
IDO inhibitor 1 is an potent inhibitor of indoleamine-2,3 dioxygenase (IDO) ( IC50 <100 nM).with potential immunomodulating and antineoplastic activities.
  • $91
In Stock
Size
QTY
EGFR/ErbB-2 inhibitor-1
T798611135150-79-6In house
EGFR/ErbB-2 inhibitor-1 is a selective ErbB2/HER2 inhibitor that effectively blocks ErbB2 and HER2 signaling.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Sale
HIV-1 inhibitor-54
T678332771211-71-1In house
HIV-1 inhibitor-54 is a potent HIV-1 inhibitor showing anti-HIV activity (EC50 : 32 nM) against WT HIV-1 (strain IIIB) x in MT-4 cells.HIV-1 inhibitor-54 can be used to study viral infections.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Pim-1 kinase inhibitor 4
T77526
Pim-1 kinase inhibitor 4 is a potent Pim-1 kinase inhibitor with an IC50 value of 17.01 nM.Pim-1 kinase inhibitor 4 also possesses antioxidant activity and potential anticancer activity, and inhibits DPPH.Pim-1 kinase inhibitor 4 promotes apoptosis and inhibits the growth of PC-3 cells with an IC50 value of 16 nM. Pim-1 kinase inhibitor 4 promotes apoptosis and inhibits PC-3 cell growth with an IC50 of 16 nM. Pim-1 kinase inhibitor 4 can be used in prostate cancer research.
  • $195
In Stock
Size
QTY
mTOR kinase Inhibitor 1
T9311321557-16-8In house
can be used in research in the fields of chemistry and life sciences.
  • $148
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Xanthine dehydrogenase Inhibitor 1
T5007180025-67-8
5-amino-1-[4-(trifluoromethyl)phenyl]-1H-pyrazole-4-carbonitrile is a compound used as a molecular structural unit and is considered to be an inhibitor of enzymes such as COX-2, 5-LOX, etc., and possesses a wide range of biochemical and physiological effects including antitumor activity, anti-inflammatory effects and antioxidant activity.
  • $126
In Stock
Size
QTY
TargetMol | Inhibitor Sale
LMPTP INHIBITOR 1 hydrochloride
T44912310135-38-5
LMPTP INHIBITOR 1 hydrochloride is a selective inhibitor of low molecular weight protein tyrosine phosphatase ( LMPTP ), with an IC 50 of 0.8 μM for LMPTP-A.
  • $258
In Stock
Size
QTY
TargetMol | Inhibitor Sale
PREP inhibitor-1
T616222760543-16-4
PREP inhibitor-1 is a prolyl oligopeptidase (PREP) inhibitor for the study of Alzheimer's disease.
  • $195
In Stock
Size
QTY
HIV-1 Inhibitor 18A
T24141331261-50-8
HIV-1 Inhibitor 18A (HIV-1 Inhibitor-18A) specifically inhibits the entry of multiple HIV-1 isolates.
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
LRRK2 inhibitor 1
T118781802525-61-6In house
LRRK2 inhibitor 1 is a selective and potent LRRK2 inhibitor with an IC50 of 13 nM.LRRK2 inhibitor 1 inhibits DCLK1 kinase with an IC50 value of 2.61 nM.
  • $68
In Stock
Size
QTY
GSK-3 inhibitor 1
T11468603272-51-1In house
GSK-3 inhibitor 1 is a GSK-3 inhibitor.
  • $106 TargetMol
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Prolyl Endopeptidase Inhibitor 1
T1254686925-97-5In house
Prolyl Endopeptidase Inhibitor 1 is a potent inhibitor of prolyl endopeptidase (PEP; PE)(Ki : 15 nM) , has anti-amnesic effect.
  • $217
5 days
Size
QTY
TargetMol | Inhibitor Sale
Lipid peroxidation inhibitor 1
T10166142873-41-4In house
Lipid peroxidation inhibitor 1 is an inhibitor of lipid peroxidation (IC50: 0.07 μM).
  • $1,670
8-10 weeks
Size
QTY
TargetMol | Inhibitor Sale
SIRT5 inhibitor 1
T129212166487-21-2In house
SIRT5 inhibitor 1 is a potent and selective inhibitor of human Sirtuin 5 deacylase (IC50: 0.11 μM). sIRT5 inhibitor 1 is associated with ageing-related diseases.
  • $148
In Stock
Size
QTY
CNT2 inhibitor-1
T10853880155-70-4In house
CNT2 inhibitor-1 is a potent inhibitor of concentrative nucleoside transporter 2 (CNT2; IC50: 640 nM for hCNT2).
  • $129
In Stock
Size
QTY
BTK inhibitor 1
T353302230724-66-8In house
BTK inhibitor 1 (Compound 27) is a BTK inhibitor (IC50: 0.11 nM) with an inhibitory effect on B-cell activation in hWB with an IC50 of 2 nM.
  • $97
In Stock
Size
QTY
ERK1/2 inhibitor 1
T112262095719-90-5In house
ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1/2 inhibitor, showing 60% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively.
  • $213
In Stock
Size
QTY
TAK1/MAP4K2 inhibitor 1
T104441315330-11-0In house
TAK1/MAP4K2 inhibitor 1 is a potent dual inhibitor of TGFβ-activated kinase 1 (TAK1) and MAP4K2 (IC50s: 41.1 nM and 18.2 nM).
  • $177
5 days
Size
QTY
IL-4-inhibitor-1
T365271332184-63-0In house
IL-4 inhibitor is an inhibitor of IL-4.1It binds to IL-4 with a Kdvalue of 1.8 μM and inhibits IL-4 activity in a cell-based reporter assay (EC50= 1.81 μM). It is selective for IL-4 over IL-13 (EC50= 18.2 μM). IL-4 inhibitor inhibits IL-4-induced STAT6 phosphorylation in THP-1 monocytes (EC50= 3.1 μM), indicating inhibition of the IL-4-JAK1-STAT6 signaling pathway.
  • $39
In Stock
Size
QTY
hSMG-1 inhibitor 11e
T355291402452-10-1In house
hSMG-1 inhibitor 11e is an effective and selective inhibitor of hSMG-1 (IC50 <0.05 nM) and can be used in studies about cancer treatment.
  • $157
In Stock
Size
QTY
Endothelial lipase inhibitor-1
T111991466427-02-0In house
Endothelial lipase inhibitor-1 is a potent endothelial lipase inhibitor with an IC50 of 49 nM.
  • $115
In Stock
Size
QTY
TargetMol | Inhibitor Sale
IL-17A inhibitor 1
T94482452464-73-0In house
IL-17A inhibitor 1 is a IL-17A inhibitor with IC50 of <9.45 nM in alphalisa assay. IL-17A inhibitor 1 inhibits HT-29 cells with IC50 of 9.3 nM.
  • $799
In Stock
Size
QTY
DGAT-1 inhibitor 2
T11016942999-61-3In house
DGAT-1 inhibitor 2 is an effective DGAT-1 inhibitor; anti-obesity drug. Objective: DGAT-1 acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step of triglyceride synthesis. The discovery of transgenic mice and pharmacological studies indicate that inhibiting DGAT1 is a promising strategy for treating obesity and type 2 diabetes.
  • $59
In Stock
Size
QTY
Cot inhibitor-1
T10865915365-57-0In house
Cot inhibitor-1 is a selective inhibitor of Cot protein kinase (also known as Tpl2 or MAP3K8) (IC50 at 28 nM). Cot inhibitor-1 inhibited TNF-alpha production in human whole blood with IC50 of 5.7 nM. Cot is involved in a variety of cellular signaling pathways, particularly those involved in inflammation and immune responses. Cot inactivate-1 inhibits Cot activity and may have potential therapeutic effects on rheumatoid arthritis, inflammatory bowel disease and some types of cancer.
  • $70
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AP-1/NF-κB activation inhibitor 1
T9656188936-12-1In house
AP-1/NF-κB activation inhibitor 1 is a potent inhibitor of AP-1 and NF-κB mediated transcriptional activation ( IC 50 =1 μM), does not blocking basal transcription driven by the β-actin promoter. AP-1/NF-κB activation inhibitor 1 has a similar inhibitory effect on the production of IL-2 and IL-8 levels in stimulated cells [1].
  • $67
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Glutaminyl Cyclase Inhibitor 1
T114242110449-60-8In house
Glutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor (IC50: 0.5 μM) that can be used to study neurological disorders.
  • $122
In Stock
Size
QTY
TargetMol | Inhibitor Sale
EML4-ALK kinase inhibitor 1
T111841373409-08-5In house
EML4-ALK kinase inhibitor 1 (EML4 ALK kinase inhibitor 1) is a potent oral active inhibitor of echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK), with an IC50 of 1 nM.
  • $88
In Stock
Size
QTY
TargetMol | Inhibitor Sale
KRas G12C inhibitor 1
T117762158297-28-8In house
KRas G12C inhibitor 1 is a compound that inhibits KRas G12C.
  • $1,670
8-10 weeks
Size
QTY
TargetMol | Inhibitor Sale
mPGES-1 Inhibitor-1
T280891381846-21-4In house
mPGES-1 Inhibitor-1 is a novel selective inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1) with anti-inflammatory and analgesic activity for the study of acute liver injury.
  • $196
In Stock
Size
QTY
hSMG-1 inhibitor 11j
T88841402452-15-6
hSMG-1 inhibitor 11j is a pyrimidine derivative. hSMG-1 inhibitor 11j is a potent and selective inhibitor of hSMG-1, IC50 = 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) and CDK1/CDK2 (IC50=32/7.1 μM). hSMG-1 inhibitor 11j can be used for the research of cancer.
  • $163 TargetMol
In Stock
Size
QTY
BRM/BRG1 ATP Inhibitor-1
T106162270879-17-7
BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1/SMARCA4 ATPase activity inhibitor (IC50s<0.005 μM).
  • $417
In Stock
Size
QTY
TargetMol | Citations Cited
PKC-iota inhibitor 1
T87642328094-11-5
PKC-iota inhibitor 1 is an inhibitor of protein kinase C-iota (PKC-ι ; IC50 : 0.34 μM)
  • $115
In Stock
Size
QTY
TargetMol | Citations Cited
VPS34 inhibitor 1 (Compound 19, PIK-III analogue)
T79441383716-46-8
VPS34 inhibitor 1 (Compound 19, PIK-III analogue) (PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM)
  • $61
In Stock
Size
QTY
TargetMol | Citations Cited
Grp94 Inhibitor-1
T72612234897-35-7
Grp94 Inhibitor-1 is a potent, selective Grp94 inhibitor (IC50 : 2 nM).
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
YAP/TAZ inhibitor-1
T133642093565-23-0
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor (IC50 <0.100 μΜ) for the study of abnormal immune function and cancer.
  • $487
5 days
Size
QTY
TargetMol | Citations Cited
B7/CD28 interaction inhibitor 1
T3189635324-72-0
B7/CD28 interaction inhibitor 1 (CTLA-4 inhibitor) is a potent CTLA-4 inhibitor.
  • $77
In Stock
Size
QTY
TargetMol | Citations Cited
ATX inhibitor 1
T104102225892-70-4
ATX inhibitor 1 is a potent ATX inhibitor (IC50: 1.23 nM, FS-3 and 2.18 nM, bis-pNPP).
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Sale
KRAS mutant protein inhibitor 1
T402722642305-16-4
KRAS mutant protein inhibitor 1 is a KRAS mutant protein inhibitor for potential treatment in cancer.
  • $970
Backorder
Size
QTY
TargetMol | Inhibitor Sale